Search
OptimizeRx Corp
OPRXAdd to Watchlist
9.090USD
+0.370+4.24%
Market hours 10/06, 09:50（ET）
170.62MMarket Cap
24.62P/E TTM
OptimizeRx Corp (OPRX) Stock Price Target & Forecast
Analyst Rating
Based on 6 analysts giving stock ratings to OptimizeRx Corp in the past month.
Buy
2 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
12.600USD+47.02%
OPRX Analyst Recommendation Trends
In the current month, OPRX has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OPRX average Analyst price target in the last month is 12.600.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2
2
2
2
2
2
2
2
4
4
4
4
4
4
4
4
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
7
7
7
7
7
7
OPRX Analyst Rating for Peer Comparison
Updated: Oct 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Meta Platforms Inc
META
18
39
6
0
0
63
Alphabet Inc Class A
GOOGL
17
38
7
0
0
62
Uber Technologies Inc
UBER
13
33
6
1
0
53
Netflix Inc
NFLX
12
27
13
0
0
52
Lyft Inc
LYFT
3
14
32
1
0
50
Shopify Inc
SHOP
9
28
9
0
1
47
DoorDash Inc
DASH
11
25
10
0
0
46
Mastercard Inc
MA
10
32
3
0
0
45
Airbnb Inc
ABNB
8
18
17
1
0
44
Spotify Technology SA
SPOT
11
21
9
0
0
41
Financial Forecasting
Based on analysts' estimates, OPRX EPS is projected to reach 0.172 in FY2026Q3, following reported EPS of -0.037 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.23
-0.04
0.08
0.17
0.43
Actual
0.27
-0.03
-0.04
--
--
Surprise
+18.67%
+31.60%
-147.97%
--
--
FAQs
What is OptimizeRx Corp's expected revenue for the next quarter?
OptimizeRx Corp's expected revenue is 21.19M.
What is OptimizeRx Corp's price target?
Analysts forecast that OptimizeRx Corp's price target is USD 12.60, with the highest forecast at USD 18.00 and the lowest forecast at USD 11.00.
How have OptimizeRx CorpOPRX's recent earnings per share performed?
The market expectation was USD -0.04, while OptimizeRx CorpOPRX's earnings per share (EPS) for the previous quarter was USD -0.03. EPS for the next quarter is expected at USD 0.17.
What is the analyst rating for OptimizeRx Corp?
Based on the ratings of OptimizeRx Corp's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.